6月23日 - ** 海斯科制药集团（002653.SZ）股价大涨9.7%至54元，有望创下自2025年10月31日以来的最大单日百分比涨幅
** 该股连续第三个交易日上涨，创下自6月1日以来的最高价
** 纽维克制药（NVCT.O）周一表示，已获得海斯科制药集团（002653.SZ）两款实验性药物的中国境外独家授权 (link)，这些药物针对补体介导性疾病和癌症，旨在扩充其产品线
** 海斯科将获得总额高达4000万美元的预付款和短期付款，并有资格获得最高14.2亿美元的额外里程碑付款，以及未来净销售额的分级特许权使用费
** 今年迄今，该公司股价上涨3.6%，基准沪深300指数 .CSI300 上涨8.1%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.